Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5697)
All Articles published online
|
Publishing Process of This Article
|
Jun 27, 2014 (publication date) through Nov 30, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Surgery
ISSN
1948-9366
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Fonseca GM, Varella AD, Coelho FF, Abe ES, Dumarco RB, Herman P. Downstaging and resection after neoadjuvant therapy for fibrolamellar hepatocellular carcinoma. World J Gastrointest Surg 2014; 6(6): 107-111 [PMID: 24976904 DOI: 10.4240/wjgs.v6.i6.107] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9366/full/v6/i6/107.htm |
| Number | Citing Articles |
| 1 |
Benjamin A. Farber, Gadi Lalazar, Elana P. Simon, William J. Hammond, David Requena, Umesh K. Bhanot, Michael P. La Quaglia, Sanford M. Simon. Non coding RNA analysis in fibrolamellar hepatocellular carcinoma. Oncotarget 2018; 9(12): 10211 doi: 10.18632/oncotarget.23325
|
| 2 |
Georgios Polychronidis, Anastasia Murtha-Lemekhova, Juri Fuchs, Evdokia Karathanasi, Katrin Hoffmann. A Multidisciplinary Approach to the Management of Fibrolamellar Carcinoma: Current Perspectives and Future Prospects. OncoTargets and Therapy 2022; : 1095 doi: 10.2147/OTT.S296127
|
| 3 |
E. Yu. Antonova, E. A. Moroz, I. A. Dzhanyan, A. Yu. Volkov, K. K. Laktionov, V. V. Breder. Optimal choice of drug antitumor treatment in patients with Fibrolamellar liver carcinoma. Meditsinskiy sovet = Medical Council 2022; (22): 130 doi: 10.21518/2079-701X-2022-16-22-130-135
|
| 4 |
Sebastian Mafeld, Jeremy French, Dina Tiniakos, Beate Haugk, Derek Manas, Peter Littler. Fibrolamellar Hepatocellular Carcinoma: Treatment with Yttrium-90 and Subsequent Surgical Resection. CardioVascular and Interventional Radiology 2018; 41(5): 816 doi: 10.1007/s00270-018-1903-6
|
| 5 |
Ju Dong Yang, Lewis R. Roberts. Zakim and Boyer's Hepatology. 2018; : 708 doi: 10.1016/B978-0-323-37591-7.00048-3
|
| 6 |
Hassan Aziz, Zachary J Brown, Seyedeh Panid Madani, Ihab R Kamel, Timothy M Pawlik. Fibrolamellar Hepatocellular Carcinoma: Comprehensive Review of Diagnosis, Imaging, and Management. Journal of the American College of Surgeons 2023; 236(2): 399 doi: 10.1097/XCS.0000000000000476
|
| 7 |
Miral Sadaria Grandhi, Timothy M. Pawlik. Managing fibrolamellar hepatocellular carcinoma. Expert Opinion on Orphan Drugs 2017; 5(2): 143 doi: 10.1080/21678707.2017.1268050
|
| 8 |
Dolores López-Terrada, Rita Alaggio. Pathology of Pediatric Gastrointestinal and Liver Disease. 2024; : 575 doi: 10.1007/978-3-031-62589-3_14
|
| 9 |
Antonio Costantino, Tamar H. Taddei. Primary Liver Tumors Other than Hepatocellular Carcinoma: Clinical and Molecular Pearls. Current Hepatology Reports 2018; 17(4): 412 doi: 10.1007/s11901-018-0426-6
|
| 10 |
E. Yu. Antonova, V. V. Breder, E. A. Moroz, K. K. Laktionov, I. A. Dzhanyan, A. Yu. Volkov. Fibrolamellar liver cancer: the modern concept. Meditsinskiy sovet = Medical Council 2020; (20): 134 doi: 10.21518/2079-701X-2020-20-134-142
|
| 11 |
Yasir Alshareefy, Chai Yu Shen, Rosheene Jeya Prekash. Exploring the molecular pathogenesis, diagnosis and treatment of fibrolamellar hepatocellular carcinoma: A state of art review of the current literature. Pathology - Research and Practice 2023; 248: 154655 doi: 10.1016/j.prp.2023.154655
|
| 12 |
Hiroki Tanaka, Susumu Hijioka, Hiromichi Iwaya, Nobumasa Mizuno, Takamichi Kuwahara, Nozomi Okuno, Ayako Ito, Naosuke Kuraoka, Shinpei Matsumoto, Masahiro Obata, Yusuke Kurita, Muneji Yasuda, Yasuhiro Shimizu, Hiroaki Kuroda, Yozo Sato, Masataka Haneda, Eiichi Sasaki, Yasushi Yatabe, Kazuo Hara. Fibrolamellar Hepatocellular Carcinoma with Multiple Lung Metastases Treated with Multidisciplinary Therapy. Internal Medicine 2018; 57(24): 3537 doi: 10.2169/internalmedicine.1243-18
|
| 13 |
Allison F. O'Neill, Alanna J. Church, Antonio R. Perez-Atayde, Raja Shaikh, Karen J. Marcus, Khashayar Vakili. Fibrolamellar carcinoma: An entity all its own. Current Problems in Cancer 2021; 45(4): 100770 doi: 10.1016/j.currproblcancer.2021.100770
|
| 14 |
Laura Depauw, Glenn De Weerdt, Ben Gys, Sofie Demeulenaere, Wouter Mebis, Dirk Ysebaert. Pediatric fibrolamellar hepatocellular carcinoma: case report and review of the literature. Acta Chirurgica Belgica 2021; 121(3): 204 doi: 10.1080/00015458.2019.1660060
|
| 15 |
Sandra Kang, Joseph Magliocca, Marty Sellers, Giorgio Roccaro, Wei Zheng, Melina Pectasides, Amber Draper, Jessica Guadagno, Bassel El-Rayes, Mehmet Akce. Successful Liver Transplantation of Recurrent Fibrolamellar Carcinoma following Clinical and Pathologic Complete Response to Triple Immunochemotherapy: A Case Report. Oncology Research and Treatment 2022; 45(7-8): 430 doi: 10.1159/000524872
|
| 16 |
Sara Gottlieb, Claire O’Grady, Ariel Gliksberg, Paul Kent. Early Experiences with Triple Immunochemotherapy in Adolescents and Young Adults with High-Risk Fibrolamellar Carcinoma. Oncology 2021; 99(5): 310 doi: 10.1159/000513358
|
| 17 |
Imane El Dika, Robert J. Mayer, Alan P. Venook, Marinela Capanu, Michael P. LaQuaglia, Rachel Kobos, Allison F. O'Neill, Joanne F. Chou, Michele Ly, Celina Ang, Eileen M. O'Reilly, John D. Gordan, Ghassan K. Abou-Alfa. A Multicenter Randomized Three-Arm Phase II Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) with Leuprolide + Letrozole, and (3) Everolimus + EDT in Patients with Unresectable Fibrolamellar Carcinoma. The Oncologist 2020; 25(11): 925 doi: 10.1634/theoncologist.2020-0367
|
| 18 |
Hideyuki Wada, Hoon Hyun, Christina Vargas, Elizabeth M. Genega, Julien Gravier, Sylvain Gioux, John V. Frangioni, Hak Soo Choi. Sentinel Lymph Node Mapping of Liver. Annals of Surgical Oncology 2015; 22(S3): 1147 doi: 10.1245/s10434-015-4601-5
|
| 19 |
Oscar Suarez, María Perez, Martin Garzon, Rodrigo Daza, Geovanny Hernandez, Carolina Salinas, Jorge Ceballos, Enrique P. de Leon, Jacqueline Mugnier, Oscar Beltrán, Adriana Varón. Fibrolamellar Hepatocellular Carcinoma and Noncirrhotic Hyperammonemic Encephalopathy. Case Reports in Hepatology 2018; 2018: 1 doi: 10.1155/2018/7521986
|
| 20 |
William J. Hammond, Gadi Lalazar, James A. Saltsman, Benjamin A. Farber, Enrico Danzer, Tshering C. Sherpa, Charles D. Banda, Jeffrey R. Andolina, Sasan Karimi, Cameron W. Brennan, Michael S. Torbenson, Michael P. La Quaglia, Sanford M. Simon. Intracranial metastasis in fibrolamellar hepatocellular carcinoma. Pediatric Blood & Cancer 2018; 65(4) doi: 10.1002/pbc.26919
|
| 21 |
Leonardo G Da Fonseca, Victor Junji Yamamoto, Mateus Trinconi Cunha, Giovanna Sawaya Torre, Raphael Araujo, Gilton Marques Fonseca, Andre Tsin Chih Chen, Aline Chagas, Paulo Herman, Venancio Avancini Ferreira Alves, Flair Jose Carrilho. Treatment Outcomes in Patients with Advanced Fibrolamellar Hepatocellular Carcinoma Under Systemic Treatment: Analysis of Clinical Characteristics, Management, and Radiomics. Journal of Hepatocellular Carcinoma 2023; : 1923 doi: 10.2147/JHC.S428741
|
| 22 |
Jairo A. Espinosa, Alex Merlo, Mohamed-Omar Arafeh, Gitonga Munene. An unusual case of jaundice: Biliary tumor thrombus in fibrolamellar hepatocellular carcinoma. International Journal of Surgery Case Reports 2017; 36: 50 doi: 10.1016/j.ijscr.2017.03.039
|